| Literature DB >> 31027300 |
Amjad H Jarrar1, Jeannette M Beasley2, Eric O Ohuma3, Leila Cheikh Ismail4, Dina A Qeshta5, Maysm N Mohamad6, Ayesha S Al Dhaheri7.
Abstract
(1) Background: Fasting during Ramadan involves large changes in daily eating patterns which strongly impacts the daily biorhythm and challenges the regular function of the digestive tract. The aim of this study was to assess satiety, bowel habits, body composition, blood glycaemia, and blood lipidemia after the consumption of high fiber cereal at dawn (Sohor) during the month of Ramadan; (2)Entities:
Keywords: Ramadan; cereal; dietary fiber; high fiber
Mesh:
Substances:
Year: 2019 PMID: 31027300 PMCID: PMC6521042 DOI: 10.3390/nu11040939
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Physical characteristics of the study population (n = 81).
| Control ( | Intervention ( | Overall | |||||
|---|---|---|---|---|---|---|---|
| Age (Year) | 21.5 ± 1.9 | 22.6 ± 5.7 | 0.289 | ||||
| Height (cm) | 161.1 ± 8.5 | 161.3 ± 5.6 | 0.888 | ||||
|
|
|
|
|
|
| ||
| Weight (kg) | 60.5 ± 11.5 | 59.9 ± 11.2 | 0.002 | 62.5 ±11.1 | 62.0 ± 11.1 | 0.003 | 0.667 |
| BMI (kg/cm²) | 23.2 ± 3.6 | 23.0 ± 3.6 | 0.002 | 24.0 ± 3.9 | 23.8 ± 3.9 | 0.004 | 0.890 |
| WC (cm) | 73.8 ± 9.0 | 74.9 ± 8.4 | 0.053 | 75.1 ± 8.0 | 75.6 ± 8.7 | 0.221 | 0.391 |
| % Body fat | 31.0 ±8.9 | 30.4 ± 9.0 | 0.059 | 34.0 ± 7.1 | 34.1 ± 7.3 | 0.808 | 0.141 |
BMI: body mass index; WC: waist circumference; M: mean; SD: standard deviation; % Body fat: body fat percentage.
Gastrointestinal symptoms experienced at the endpoint of Ramadan.
| Gastrointestinal | Response/Frequency | Control ( | Intervention ( | |
|---|---|---|---|---|
| Bowel habits increase | Yes | 9 (25) | 22 (49) | 0.029 |
| No | 27 (75) | 23 (51) | ||
| Constipation | Yes | 3 (8) | 2 (4) | 0.417 |
| Bowel movement frequency | ≤1/week | 6 (16.6) | 4 (9) | 0.294 |
| 2/week | 8 (22.2) | 12 (27) | ||
| ≥3/week | 22 (61.1) | 29 (64) | ||
| Vomiting frequency | None | 23 (64) | 34 (75.5) | 0.467 |
| 1–2/week | 13 (36) | 11 (24.5) | ||
| Bloating frequency | ≤1/week | 18 (50) | 28 (62.2) | <0.001 |
| 2/week | 13 (36) | 12 (26.6) | ||
| ≥3/week | 5 (14) | 5 (11.1) | ||
| Heartburn frequency | ≤1/week | 23 (64) | 29 (64.4) | 0.418 |
| 2/week | 9 (25) | 12 (26.6) | ||
| ≥3/week | 4 (11) | 4 (9) |
Satiety scale at the endpoint of Ramadan for control and intervention groups.
| Time | Control ( | Intervention ( | ||||
|---|---|---|---|---|---|---|
| Neutral | Hungry | Satisfied | Neutral | Hungry | Satisfied | |
| Before Sohor meal immediately | 6 (16.6) | 19 (52.8) | 11 (30.6) | 9 (20.0) | 22 (48.9) | 14 (31.1) |
| 15 min after Sohor meal | 16 (44.4) | 1 (3) | 19 (52.7) | 0 (0) | 0 (0) | 45 (100) |
| At wakeup immediately | 19 (52.7) | 6 (16.7) | 11 (30.6) | 15 (33.3) | 5 (11.1) | 25 (55.6) |
| At 12:00 pm | 12 (33.3) | 19 (52.8) | 5 (13.9) | 18 (40.0) | 10 (22.2) | 17 (37.8) |
| 2 h prior Iftar meal | 6 (16.7) | 27 (75.0) | 3 (8.3) | 9 (20) | 29 (64.4) | 7 (15.6) |
| At Iftar meal | 7 (19.4) | 27 (75.0) | 2 (5.5) | 7 (15.5) | 34 (75.6) | 4 (8.9) |
Figure 1Subjective satiety rating for ‘satisfied’ for the control and intervention groups at the endpoint of Ramadan (* p-value < 0.05).
Macronutrient intake of the control and intervention groups at baseline and endpoint during Ramadan.
| Control ( | Intervention ( | Overall | |||||
|---|---|---|---|---|---|---|---|
| Baseline | Endpoint | Baseline | Endpoint | ||||
| Energy (kcal) | 1913 ± 154 | 1876 ± 123 | 0.480 | 2021 ± 108 | 1939 ± 71 | 0.480 | 0.957 |
| Carbohydrate (g) | 244 ± 30 | 220 ± 16 | 0.343 | 266 ± 8 | 264 ±11 | 0.602 | 0.048 |
| Protein (g) | 64.4 ± 4.9 | 66.4 ± 4.6 | 0.935 | 66.1 ± 4.8 | 60.9 ± 2.6 | 0.348 | 0.931 |
| Fat (g) | 68.9 ± 5.5 | 74.8 ± 6.3 | 0.431 | 69.2 ± 7.9 | 65.4 ± 3.9 | 0.667 | 0.784 |
| Dietary fiber (g) | 18.5 ± 1.8 | 18.6 ± 1.3 | 0.901 | 17.8 ± 1.7 | 25.6 ± 1. | <0.001 | <0.001 |
% of total Kcal: percent of total calories; % of RDA: percent of recommended daily allowance; M: mean; SD: standard deviation.
Biochemical measurements of the study population.
| Control ( | Intervention ( | Overall | |||||
|---|---|---|---|---|---|---|---|
| Baseline | Endpoint | Baseline | Endpoint | ||||
| Glucose (mg) | 85.7 ± 11.0 | 89.9 ± 12.2 | 0.092 | 83.7 ± 13.5 | 83.6 ± 15.2 | 0.991 | 0.271 |
| Total cholesterol (mg) | 149.5 ± 32.3 | 167.7 ± 33.6 | 0.012 | 140.7 ± 34.4 | 138.8 ± 42.8 | 0.778 | 0.043 |
| HDL cholesterol (mg) | 53.3 ± 14.8 | 53.5 ± 13.7 | 0.921 | 50.6 ± 14.3 | 51.1 ± 15.3 | 0.815 | 0.922 |
| LDL cholesterol (mg) | 81.6 ± 23.8 | 96.3 ± 26.3 | 0.006 | 77.6 ± 29.0 | 78.7 ± 28.6 | 0.786 | 0.033 |
| Triglycerides (mg) | 65.8 ± 18.9 | 77.1 ± 32.7 | 0.083 | 64.2 ± 19.8 | 71.5 ± 31.6 | 0.180 | 0.631 |
HDL: high density lipoprotein; LDL: low density lipoprotein; M: mean; SD: standard deviation.